期刊文献+
共找到11篇文章
< 1 >
每页显示 20 50 100
Animal models of hepatitis E infection: Advances and challenges
1
作者 ze xiang xiang-Lin He +5 位作者 Chuan-Wu Zhu Jia-Jia Yang Lan Huang Chun Jiang Jian Wu Chinese Consortium for the Study of Hepatitis E(CCSHE) 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2024年第2期171-180,共10页
Hepatitis E virus(HEV)is one of the leading causes of acute viral hepatitis worldwide.Although most of HEV infections are asymptomatic,some patients will develop the symptoms,especially pregnant women,the elderly,and ... Hepatitis E virus(HEV)is one of the leading causes of acute viral hepatitis worldwide.Although most of HEV infections are asymptomatic,some patients will develop the symptoms,especially pregnant women,the elderly,and patients with preexisting liver diseases,who often experience anorexia,nausea,vom-iting,malaise,abdominal pain,and jaundice.HEV infection may become chronic in immunosuppressed individuals.In addition,HEV infection can also cause several extrahepatic manifestations.HEV exists in a wide range of hosts in nature and can be transmitted across species.Hence,animals susceptible to HEV can be used as models.The establishment of animal models is of great significance for studying HEV transmission,clinical symptoms,extrahepatic manifestations,and therapeutic strategies,which will help us understand the pathogenesis,prevention,and treatment of hepatitis E.This review summarized the animal models of HEV,including pigs,monkeys,rabbits,mice,rats,and other animals.For each animal species,we provided a concise summary of the HEV genotypes that they can be infected with,the cross-species transmission pathways,as well as their role in studying extrahepatic manifestations,prevention,and treatment of HEV infection.The advantages and disadvantages of these animal models were also emphasized.This review offers new perspectives to enhance the current understanding of the research landscape surrounding HEV animal models. 展开更多
关键词 Hepatitis E virus Animal models PATHOGENESIS PREVENTION Treatment
下载PDF
Comment on“Robotic surgery and liver transplantation:A single-center experience of 501 robotic donor hepatectomies”
2
作者 xiang-Yan Liu Yun-Yang Xu +1 位作者 ze xiang Shu-Sen Zheng 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2024年第1期109-110,共2页
To the Editor:We read with great interest the article by Schulze et al.entitled“Robotic surgery and liver transplantation:A single-center experience of 501 robotic donor hepatectomies”[1].It is the first single-cent... To the Editor:We read with great interest the article by Schulze et al.entitled“Robotic surgery and liver transplantation:A single-center experience of 501 robotic donor hepatectomies”[1].It is the first single-center report including over 500 fully robotic donor hepatectomies.For the donors,the overall complication rate was 6.4%(n=32).Postoperative self-limiting bleeding(0.4%)and bile leakage from the resection plane(1.8%)were rare. 展开更多
关键词 ROBOTIC ROBOTIC CENTER
下载PDF
Familial hypercholesterolemia:Current limitations and future breakthroughs
3
作者 ze xiang Jia-Rui Li +2 位作者 Wei-Min Wan Shu-Hui Li Jian Wu 《World Journal of Experimental Medicine》 2024年第4期174-177,共4页
Familial hypercholesterolemia(FH)is characterized by elevated low-density lipoprotein cholesterol levels due to genetic mutations,presenting with xanthomas,corneal arch,and severe cardiovascular diseases.Early identif... Familial hypercholesterolemia(FH)is characterized by elevated low-density lipoprotein cholesterol levels due to genetic mutations,presenting with xanthomas,corneal arch,and severe cardiovascular diseases.Early identification,diagnosis,and treatment are crucial to prevent severe complications like acute myocardial infarction.Statins are the primary treatment,supplemented by Ezetimibe and proprotein convertase subtilisin/kexin type 9 inhibitors,though their effectiveness can be limited in severe cases.Over 90%of FH cases remain undiagnosed,and current treatments are often inadequate,underscoring the need for improved diagnostic and management systems.Future strategies include advancements in gene testing,precision medicine,and novel drugs,along with gene therapy approaches like AAV-mediated gene therapy and clustered regularly interspaced short palindromic repeats.Lifestyle modifications,including health education,dietary control,and regular exercise,are essential for managing FH and preventing related diseases.Research into FH-related gene mutations,especially LDLR,is critical for accurate diagnosis and effective treatment. 展开更多
关键词 Familial hypercholesterolemia Genetic mutations TREATMENT LIMITATIONS Breakthroughs
下载PDF
Realm of hepatitis E:Challenges and opportunities
4
作者 Jia-Rui Li ze xiang +3 位作者 Shu-Hui Li Chen-Xi Li Hong Yan Jian Wu 《World Journal of Experimental Medicine》 2024年第2期1-4,共4页
Hepatitis E virus(HEV),responsible for widespread viral hepatitis,infects approximately 2.3 billion individuals globally,with a significant mortality burden in Asia.The virus,primarily transmitted through contaminated... Hepatitis E virus(HEV),responsible for widespread viral hepatitis,infects approximately 2.3 billion individuals globally,with a significant mortality burden in Asia.The virus,primarily transmitted through contaminated water and undercooked meat,is often underdiagnosed,particularly in immunocompromised patients.Current HEV treatments,while effective,are limited by adverse effects,necessitating research into safer alternatives.Moreover,HEV’s extrahepatic manifestations,impacting the nervous and renal systems,remain poorly understood.This study underscores the imperative for enhanced HEV research,improved diagnostic methods,and more effective treatments,coupled with increased public health awareness and preventive strategies. 展开更多
关键词 Hepatitis E TREATMENT Extrahepatic manifestations CHALLENGES OPPORTUNITIES
下载PDF
Radiomics in the diagnosis and treatment of hepatocellular carcinoma 被引量:7
5
作者 Chun Jiang Yi-Qi Cai +5 位作者 Jia-Jia Yang Can-Yu Ma Jia-Xi Chen Lan Huang ze xiang Jian Wu 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2023年第4期346-351,共6页
Hepatocellular carcinoma(HCC)is a common malignant tumor.At present,early diagnosis of HCC is dif-ficult and therapeutic methods are limited.Radiomics can achieve accurate quantitative evaluation of the lesions withou... Hepatocellular carcinoma(HCC)is a common malignant tumor.At present,early diagnosis of HCC is dif-ficult and therapeutic methods are limited.Radiomics can achieve accurate quantitative evaluation of the lesions without invasion,and has important value in the diagnosis and treatment of HCC.Radiomics fea-tures can predict the development of cancer in patients,serve as the basis for risk stratification of HCC patients,and help clinicians distinguish similar diseases,thus improving the diagnostic accuracy.Further-more,the prediction of the treatment outcomes helps determine the treatment plan.Radiomics is also helpful in predicting the HCC recurrence,disease-free survival and overall survival.This review summa-rized the role of radiomics in the diagnosis,treatment and prognosis of HCC. 展开更多
关键词 Hepatocellular carcinoma Radiomics DIAGNOSIS PROGNOSIS TREATMENT
下载PDF
Role of tumor-associated macrophages in common digestive system malignant tumors 被引量:2
6
作者 Yue Shen Jia-Xi Chen +3 位作者 Ming Li ze xiang Jian Wu Yi-Jin Wang 《World Journal of Gastrointestinal Oncology》 SCIE 2023年第4期596-616,共21页
Many digestive system malignant tumors are characterized by high incidence and mortality rate.Increasing evidence has revealed that the tumor microenvironment(TME)is involved in cancer initiation and tumor progression... Many digestive system malignant tumors are characterized by high incidence and mortality rate.Increasing evidence has revealed that the tumor microenvironment(TME)is involved in cancer initiation and tumor progression.Tumor-associated macrophages(TAMs)are a predominant constituent of the TME,and participate in the regulation of various biological behaviors and influence the prognosis of digestive system cancer.TAMs can be mainly classified into the antitumor M1 phenotype and protumor M2 phenotype.The latter especially are crucial drivers of tumor invasion,growth,angiogenesis,metastasis,immunosuppression,and resistance to therapy.TAMs are of importance in the occurrence,development,diagnosis,prognosis,and treatment of common digestive system malignant tumors.In this review,we summarize the role of TAMs in common digestive system malignant tumors,including esophageal,gastric,colorectal,pancreatic and liver cancers.How TAMs promote the development of tumors,and how they act as potential therapeutic targets and their clinical applications are also described. 展开更多
关键词 Tumor-associated macrophages Digestive system malignant tumors Tumor development Therapeutic targets Clinical applications
下载PDF
Gut Microbiota Modulation:A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation 被引量:1
7
作者 ze xiang Jian Wu +3 位作者 Jiarui Li Shusen Zheng Xuyong Wei Xiao Xu 《Engineering》 SCIE EI CAS CSCD 2023年第10期59-72,共14页
Hepatocellular carcinoma(HCC)is the most common malignancy of the liver,posing a significant threat to public health.Although liver transplantation(LT)is an effective treatment for HCC,ischemia–reperfusion(I/R)injury... Hepatocellular carcinoma(HCC)is the most common malignancy of the liver,posing a significant threat to public health.Although liver transplantation(LT)is an effective treatment for HCC,ischemia–reperfusion(I/R)injury,transplant rejection,and complications after LT can greatly reduce its effectiveness.In recent years,transplant oncology has come into being,a comprehensive discipline formed by the intersection and integration of surgery,oncology,immunology,and other related disciplines.Gut microbiota,an emerging field of research,also plays a crucial role.Through the microbiome–gut–liver axis,the gut microbiota has an impact on the onset and progression of HCC as well as LT.This review summarizes the mechanisms by which the gut microbiota affects HCC and its bidirectional interactions with chronic liver disease that can develop into HCC as well as the diagnostic and prognostic value of the gut microbiota in HCC.In addition,gut microbiota alterations after LT were reviewed,and the relationship between the gut microbiota and liver I/R injury,the efficacy of immunosuppressive drugs used,and complications after LT were discussed.In the era of LT oncology,the role of the gut microbiota in HCC and LT should be emphasized,which can provide new insights into the management of HCC and LT via gut microbiota modulation. 展开更多
关键词 Gut microbiota Hepatocellular carcinoma(HCC) Liver transplantation(LT) Clinical value Mediating mechanism
下载PDF
Comparison of evaluation indexes for Gastroenterology and Hepatology journals in different databases
8
作者 Jia-Yuan Li Zhi-Han Yan +2 位作者 ze xiang Ce Gao Jian Wu 《World Journal of Gastroenterology》 SCIE CAS 2022年第38期5648-5657,共10页
BACKGROUND Accurate assessment of the quality of academic journals is of great significance.While Journal Impact Factor(JIF),calculated by Clarivate and based upon the Web of Science literature database,and CiteScore(... BACKGROUND Accurate assessment of the quality of academic journals is of great significance.While Journal Impact Factor(JIF),calculated by Clarivate and based upon the Web of Science literature database,and CiteScore(CS),developed by Elseiver and based upon the Scopus database,have enjoyed high uptake worldwide,efforts continue towards creation of other scientometric indexes that will provide evergreater qualitative insights into journal impact.Such efforts have yielded the newly-launched Journal Article Influence Index(JAII),which is based on the Reference Citation Analysis(RCA)database,an open multidisciplinary citation analysis database based on artificial intelligence technology.AIM To evaluate and summarize the similarities and differences between JAII and JIF/CS as journal evaluation indicators,and provide an intuitive method for visual representation of the related data.METHODS We searched the Journal Citation Reports to obtain the 2021 JIF list,downloaded the CS list updated in July on the Scopus website,and collected the comprehensive list of 2022 JAIIs from the RCA database(www.referencecitationanalysis.com).RESULTS Our research results revealed that by breaking through the time limit of mainstream journalevaluation methods, the JAII is able to perform well in data reliability, establishing its benefit as acomplementary scientometric index to JIF and CS.CONCLUSIONJAII provides comprehensive assessment of the quality and performance of journals. 展开更多
关键词 Journal Article Influence Index Journal Impact Factor CiteScore Gastroenterology and Hepatology Scientometric index
下载PDF
Roles of cancer stem cells in gastrointestinal cancers
9
作者 Shi-Hai Xuan Meng-Lu Hua +5 位作者 ze xiang xiang-Lin He Lan Huang Chun Jiang Peng Dong Jian Wu 《World Journal of Stem Cells》 SCIE 2023年第4期209-220,共12页
Cancer stem cells(CSCs)are the main cause of tumor growth,invasion,metastasis and recurrence.Recently,CSCs have been extensively studied to identify CSCspecific surface markers as well as signaling pathways that play ... Cancer stem cells(CSCs)are the main cause of tumor growth,invasion,metastasis and recurrence.Recently,CSCs have been extensively studied to identify CSCspecific surface markers as well as signaling pathways that play key roles in CSCs self-renewal.The involvement of CSCs in the pathogenesis of gastrointestinal(GI)cancers also highlights these cells as a priority target for therapy.The diagnosis,prognosis and treatment of GI cancer have always been a focus of attention.Therefore,the potential application of CSCs in GI cancers is receiving increasing attention.This review summarizes the role of CSCs in GI cancers,focusing on esophageal cancer,gastric cancer,liver cancer,colorectal cancer,and pancreatic cancer.In addition,we propose CSCs as potential targets and therapeutic strategies for the effective treatment of GI cancers,which may provide better guidance for clinical treatment of GI cancers. 展开更多
关键词 Cancer stem cells Gastrointestinal cancers PROMOTION INHIBITION TREATMENT
下载PDF
血清氨甲酰磷酸合成酶1在戊型肝炎急性肝衰竭患者的表达及其预后价值
10
作者 吴健 向泽 +3 位作者 翟光华 商安全 梁炜 李冬 《中华检验医学杂志》 CAS CSCD 北大核心 2023年第1期62-67,共6页
目的分析戊型肝炎急性肝衰竭(HEV-ALF)患者血清氨甲酰磷酸合成酶1(CPS1)水平与患者预后的相关性,评估血清CPS1水平对HEV-ALF患者30 d病死率的预测价值。方法收集2018年12月至2019年6月浙江大学医学院附属第一医院等6家医院的100例HEV-AL... 目的分析戊型肝炎急性肝衰竭(HEV-ALF)患者血清氨甲酰磷酸合成酶1(CPS1)水平与患者预后的相关性,评估血清CPS1水平对HEV-ALF患者30 d病死率的预测价值。方法收集2018年12月至2019年6月浙江大学医学院附属第一医院等6家医院的100例HEV-ALF患者、100例急性戊型肝炎(AHE)患者以及100名健康人群3组资料进行回顾性分析。根据HEV-ALF患者30 d随访期内是否死亡,分为死亡(n=21)和生存(n=79)亚组;根据HEV-ALF患者血清CPS1的中位数水平,分为高CPS1水平(n=50)和低CPS1水平(n=50)亚组;根据HEV-ALF患者病情变化情况,分为病情好转(n=55)、病情波动(n=32)和病情恶化(n=13)亚组。收集所有纳入对象的一般资料。通过酶联免疫吸附试验检测血清CPS1水平。采用Kaplan-Meier曲线比较高CPS1水平和低CPS1水平患者的生存时间。通过线性回归分析血清CPS1水平与HEV-ALF患者丙氨酸转氨酶和总胆红素水平的相关性。用受试者工作特征曲线评价血清CPS1水平预测HEV-ALF患者30 d病死率的效能。结果HEV-ALF组血清CPS1水平高于AHE组[958.6(665.5,1105.8)pg/ml比549.4(495.0,649.1)pg/ml,P<0.001],AHE组血清CPS1水平高于健康人群[549.4(495.0,649.1)pg/ml比469.9(373.3,564.5)pg/ml,P<0.001]。HEV-ALF患者生存亚组的血清CPS1水平低于死亡亚组[922.6(652.7,1042.3)pg/ml比1252.8(933.3,1555.8)pg/ml,P<0.001],且高CPS1水平HEV-ALF患者的生存时间低于低CPS1水平患者[24.59(22.11,27.06)d比28.16(26.25,30.07)d,P=0.045]。与入院时CPS1水平比较,波动和恶化亚组血清CPS1水平升高,而好转亚组降低(P均<0.01)。此外,患者血清CPS1水平与丙氨酸转氨酶和总胆红素呈正相关(r=0.339、0.304,P均<0.01)。血清CPS1水平预测HEV-ALF患者30 d病死率的曲线下面积为0.803(95%CI 0.666~0.941),敏感度为66.67%,特异度为97.47%。结论血清CPS1水平在HEV-ALF患者中高表达,且与患者的预后密切相关。 展开更多
关键词 戊型肝炎 急性肝衰竭 氨甲酰磷酸合成酶 预后
原文传递
Seasonal coronaviruses and SARS-CoV-2:effects of preexisting immunity during the COVID-19 pandemic
11
作者 Gang WANG ze xiang +1 位作者 Wei WANG Zhi CHEN 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2022年第6期451-460,共10页
Although the coronavirus disease 2019(COVID-19)epidemic is still ongoing,vaccination rates are rising slowly and related treatments and drugs are being developed.At the same time,there is increasing evidence of preexi... Although the coronavirus disease 2019(COVID-19)epidemic is still ongoing,vaccination rates are rising slowly and related treatments and drugs are being developed.At the same time,there is increasing evidence of preexisting immunity against severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)in humans,mainly consisting of preexisting antibodies and immune cells(including T cells and B cells).The presence of these antibodies is mainly due to the seasonal prevalence of four common coronavirus types,especially OC43 and HKU1.The accumulated relevant evidence has suggested that the target of antibodies is mainly the S2 subunit of S protein,followed by evolutionary conservative regions such as the nucleocapsid(N)protein.Additionally,preexisting memory T and B cells are also present in the population.Preexisting antibodies can help the body protect against SARS-CoV-2 infection,reduce the severity of COVID-19,and rapidly increase the immune response post-infection.These multiple effects can directly affect disease progression and even the likelihood of death in certain individuals.Besides the positive effects,preexisting immunity may also have negative consequences,such as antibody-dependent enhancement(ADE)and original antigenic sin(OAS),the prevalence of which needs to be further established.In the future,more research should be focused on evaluating the role of preexisting immunity in COVID-19 outcomes,adopting appropriate policies and strategies for fighting the pandemic,and vaccine development that considers preexisting immunity. 展开更多
关键词 Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) Coronavirus disease 2019(COVID-19) Preexisting immunity Seasonal coronaviruses Vaccine
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部